IFNA1 and neoplasm: Preclinical reports in mouse tumor models show the significance of host immune mechanisms in the exerting prolonged antitumor functions following the treatment of an animal with IFN-α and IFN-β (82); however, IFN-α may cause some untoward effects because of its short half-life and high dose (81).